#32USNASDAQ

DXCM

Dexcom

$89.71USD

Data as of 2026-09-05

Composite Score68.6Strong

≤−99

Margin of safety−329%Expensive

Fair value$20.89

Target$74.81

Loss chance53%Neutral

SizeLarge cap

SectorHealth Care

Dividend—

TypeCommon stock

Price

Pillar breakdown

0–100 percentile rank against the current universe (sector-relative for Quality / Value / Growth / Profitability)

Health Care median (n=163)

Quality
Profit margins & asset efficiency
89
Exceptional
Health Care median (n=163) 51
Value
Price vs fundamentals
28
Weak
Health Care median (n=163) 51
Growth
Revenue & earnings trajectory
89
Exceptional
Health Care median (n=163) 50
Momentum
Recent price strength
70
Exceptional
Health Care median (n=163) 62
Health
Balance sheet & solvency
82
Exceptional
Health Care median (n=163) 56
Profitability
ROE, ROA, ROIC
79
Exceptional
Health Care median (n=163) 49
Technical
Trend & volatility signals
67
Strong
Health Care median (n=163) 62
Risk
Volatility & drawdown profile
37
Weak
Health Care median (n=163) 47

025405570100

Exceptional (70+)Strong (55–70)Average (40–55)Weak (25–40)Poor (<25)

Pillars not shown: Sentiment, ML (Phase 5+).

Recent regulatory events

Auditor change (8-K Item 4.01)AnnotateView filing

Latest 8-K: 2025-03-25

Fair price check

6 different valuation methods each estimate what DXCM should be worth, then we compare to today's price.

Heavily overvalued

Models suggest DXCM is far above estimated fair value

Today's price

$89.71

Median fair price

$20.89

-77% vs today's price

Of 4 methods:4 say pricey(2 outliers excluded)

EV/EBITDAOvervalued
thinks it's expensive — estimates $74.81, about 17% below today
P/E multiplesOvervalued
thinks it's expensive — estimates $73.99, about 18% below today
P/B multiplesOvervalued
thinks it's expensive — estimates $21.32, about 76% below today
DCF (2-stage)Overvalued
thinks it's expensive — estimates $20.46, about 77% below today
Graham (defensive)Outlier
estimate looks unreliable — estimates $15.45 — likely unreliable
Residual IncomeOutlier
estimate looks unreliable — estimates $13.80 — likely unreliable

How to read this: “Cheap” = method's fair price is at least 20% above today. “Fair” = within ±10–20%. “Pricey” = at least 10% below today. Outliers (values more than 5× or less than 0.2× today's price) are excluded.

Fair price ensemble

Median fair: $20.89
Margin of safety(vs fair value): < −99%
Max (ex-outliers): $74.81
Tangible BVPS: $6.61

Extreme Graham estimate
Extreme Residual-Income estimate

Median of all applicable methods (current price $89.71). Per-method estimates + each method’s cheap/fair/pricey read are in the Fair price check above. Outliers above 5× or below 0.2× current price are excluded from the max but kept in the median. See methodology for the 6-method ensemble + 7 defenses.

Defense layer. Flags mark elevated risk, never confirmed fraud. This model cannot catch every manipulation and decays after publication — weigh it against its stated error rates.

Supporting dataRaw fundamentals & data-quality provenance behind the scores above

Raw fundamentals (SEC EDGAR)

Metric	Value
Market cap	$33.85B
Revenue (TTM)	$4.97B
Net income (TTM)	$999.70M
Operating cash flow (TTM)	$1.75B
CapEx (TTM)	$343.70M
Free cash flow (TTM)CFO − CapEx	$1.41B
Total assets	$6.46B
Total liabilities	$3.83B
Stockholders' equity	$2.62B
Cash & equivalents	$1.10B
Shares outstanding	377.36M
EPS (basic)	$2.65
EPS (diluted)	$2.65
P/E ratio (TTM)	33.86

TTM = trailing twelve months. Balance sheet items are point-in-time (latest filing).

Data quality

Latest filed date: 2026-07-30
Latest period end: 2026-07-23
Filing lag: 37 days
Missing metrics: 3(dividends_paid, accounts_payable, short_term_debt)

Composite is the 8-pillar weighted score over quality, value, growth, momentum, health, profitability, technical, and risk. Sentiment + ML pillars are reserved for a later phase; until then their weight redistributes pro-rata. Fair price is the median of 6 valuation methods (Graham, P/E / P/B / EV-EBITDA multiples, RIM, DCF) with outliers above 5× current price excluded from the max. Risk-overlay flags annotate only — they suppress the entered-top-5 badge but do not modify the composite.